Literature DB >> 20333467

Bilobalide prevents apoptosis through activation of the PI3K/Akt pathway in SH-SY5Y cells.

Chun Shi1, Fengming Wu, David T Yew, Jie Xu, Yonghong Zhu.   

Abstract

Bilobalide, a sesquiterpene trilactone constituent of Ginkgo biloba leaf extracts, has been proposed to exert protective and trophic effects on neurons. However, mechanisms underlying the protective effects of bilobalide remain unclear. Using human SH-SY5Y neuroblastoma cells and primary hippocampal neurons, this study investigated the neuroprotective effects of bilobalide. We mimicked aging-associated neuronal impairments by applying external factors (beta amyloid protein (Abeta) 1-42, H(2)O(2) and serum deprivation) consequently inducing cell apoptosis. As markers for apoptosis, cell viability, DNA fragmentation, mitochondrial membrane potential and levels of cleaved caspase 3 were measured. We found that, bilobalide prevented Abeta 1-42-, H(2)O(2)- and serum deprivation-induced apoptosis. To better understand the neuroprotective effects of bilobalide, we also tested the ability of bilobalide to modulate pro-survival signaling pathways such as protein kinase C (PKC), extracellular-regulated kinase 1/2 (ERK1/2) and phosphatidylinositol 3-kinase (PI3K)/Akt pathways. It was found that, bilobalide dose-dependently increased PI3K activity and levels of phosphorylated Akt (p-Akt Ser473 and Thr308), which could be maintained up to at least 2 h after bilobalide withdrawal in cells treated with or without Abeta 1-42, H(2)O(2) or serum-free medium. In addition, application of PI3K/Akt inhibitor LY294002 could abrogate both the protective effects of bilobalide against Abeta 1-42-, H(2)O(2)- and serum deprivation-induced apoptotic cell damage and bilobalide-induced increase in PI3K activity and levels of p-Akt (Ser473 and Thr308). In contrast, application of PKC inhibitor staurosporine (STS) did not affect the protective effects of bilobalide. Moreover, no change in levels of phosphorylated ERK1/2 (p-ERK1/2) was observed in bilobalide-treated cells. These results further suggested that the PI3K/Akt pathway might be involved in the protective effects of bilobalide. Since modern technology allows production of purified bilobalide with high bioavailability, bilobalide may be useful in developing therapy for diseases involving age-associated neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333467     DOI: 10.1007/s10495-010-0492-x

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  22 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3β pathway mediates bilobalide-induced reduction in amyloid β-peptide.

Authors:  Chun Shi; Dong-dan Zheng; Feng-ming Wu; Jun Liu; Jie Xu
Journal:  Neurochem Res       Date:  2011-09-28       Impact factor: 3.996

3.  JNK/PI3K/Akt signaling pathway is involved in myocardial ischemia/reperfusion injury in diabetic rats: effects of salvianolic acid A intervention.

Authors:  Qiuping Chen; Tongda Xu; Dongye Li; Defeng Pan; Pei Wu; Yuanyuan Luo; Yanfeng Ma; Yang Liu
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  Anti-aging Klotho Protects SH-SY5Y Cells Against Amyloid β1-42 Neurotoxicity: Involvement of Wnt1/pCREB/Nrf2/HO-1 Signaling.

Authors:  Mohsen Sedighi; Tourandokht Baluchnejadmojarad; Siamak Afshin-Majd; Mona Amiri; Malihe Aminzade; Mehrdad Roghani
Journal:  J Mol Neurosci       Date:  2020-07-05       Impact factor: 3.444

5.  Effect of ginkgolide B on brain metabolism and tissue oxygenation in severe haemorrhagic stroke.

Authors:  Chun-Ling Chi; Dong-Fang Shen; Peng-Jun Wang; Hu-Lun Li; Li Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 6.  Cell survival signaling in neuroblastoma.

Authors:  Michael L Megison; Lauren A Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

7.  Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.

Authors:  Feng Chen; Li Li; Fang Xu; Yan Sun; Feifei Du; Xutao Ma; Chenchun Zhong; Xiuxue Li; Fengqing Wang; Nating Zhang; Chuan Li
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

8.  Effects of DL-3-n-butylphthalide on vascular dementia and angiogenesis.

Authors:  Lihong Zhang; Lanhai Lü; W M Chan; Yin Huang; Maria S M Wai; David T Yew
Journal:  Neurochem Res       Date:  2012-01-14       Impact factor: 3.996

9.  Neuroprotective effects of bilobalide are accompanied by a reduction of ischemia-induced glutamate release in vivo.

Authors:  Dorothee Lang; Cornelia Kiewert; Alexander Mdzinarishvili; Tina Maria Schwarzkopf; Rachita Sumbria; Joachim Hartmann; Jochen Klein
Journal:  Brain Res       Date:  2011-10-06       Impact factor: 3.252

10.  Protective effect of ginkgolide B against acute spinal cord injury in rats and its correlation with the Jak/STAT signaling pathway.

Authors:  Yongxing Song; Zhongyou Zeng; Caiyi Jin; Jianqiao Zhang; Baoyue Ding; Feng Zhang
Journal:  Neurochem Res       Date:  2012-12-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.